According to Regeneron Pharmaceuticals's latest financial reports the company has $25.97 B in net assets.
A companyโs net assets is the sum of its assets minus the sum of its liabilities.
Year | Net assets | Change |
---|---|---|
2023-12-31 | $25.97 B | 14.6% |
2022-12-31 | $22.66 B | 20.75% |
2021-12-31 | $18.76 B | 70.23% |
2020-12-31 | $11.02 B | -0.58% |
2019-12-31 | $11.08 B | 26.63% |
2018-12-31 | $8.75 B | 42.53% |
2017-12-31 | $6.14 B | 38.09% |
2016-12-31 | $4.44 B | 21.74% |
2015-12-31 | $3.65 B | 43.31% |
2014-12-31 | $2.55 B | 30.64% |
2013-12-31 | $1.95 B | 56.74% |
2012-12-31 | $1.24 B | 156.39% |
2011-12-31 | $0.48 B | -7.97% |
2010-12-31 | $0.52 B | 33.03% |
2009-12-31 | $0.39 B | -5.87% |
2008-12-31 | $0.42 B | -8.42% |
2007-12-31 | $0.46 B | 112.47% |
2006-12-31 | $0.21 B | 90.02% |
2005-12-31 | $0.11 B | -37.55% |
2004-12-31 | $0.18 B | 32.62% |
2003-12-31 | $0.13 B | -5.71% |
2002-12-31 | $0.14 B | -45.19% |
2001-12-31 | $0.26 B |
Company | Net assets | differencediff. | Country |
---|---|---|---|
Johnson & Johnson JNJ | $68.77 B | 164.79% | ๐บ๐ธ USA |
Novartis NVS | $46.75 B | 79.99% | ๐จ๐ญ Switzerland |
Amgen AMGN | $6.23 B | -76.01% | ๐บ๐ธ USA |
Sanofi SNY | $82.20 B | 216.49% | ๐ซ๐ท France |
Biogen BIIB | $14.79 B | -43.02% | ๐บ๐ธ USA |
Alnylam Pharmaceuticals
ALNY | -$0.23 B | -100.85% | ๐บ๐ธ USA |